Blood Pressure Heart Failure Kidney Disease 
Circulation
NOVEMBER 11, 2024
Introduction:Smoking is a well-known risk factor for atherosclerotic cardiovascular disease and kidney failure among patients with chronic kidney disease (CKD). However, the association of former and current smoking status (vs.
CardiacWire
OCTOBER 6, 2024
Finerenone is a non-steroidal, selective mineralocorticoid receptor antagonist (nsMRA), blocking the mineralocorticoid receptor and its blood pressure effects. Finerenone is already approved to reduce cardiovascular and kidney disease risks in patients with type 2 diabetes-associated CKD, but not for HF.
Dr. Paddy Barrett
JULY 5, 2024
We do a terrible job of identifying and managing high blood pressure. And we still do an awful job of identifying and managing high blood pressure. As a risk factor for death, high blood pressure is responsible for more deaths than any other risk factor, including smoking. What Is Normal Blood Pressure?
Journal of the American Heart Association
MARCH 18, 2024
Classically, activation of the MR in the renal tubular epithelium is responsible for sodium retention and volume expansion, raising systemic blood pressure.
Open Heart
OCTOBER 31, 2024
Background Heart failure (HF) is a leading cause of morbidity and mortality worldwide. Results Baseline characteristics revealed significant differences between NUA and HUA groups, with the latter exhibiting a higher prevalence of males, chronic kidney disease (CKD) and elevated levels of various biomarkers.
Cardiometabolic Health Congress
NOVEMBER 14, 2024
Additionally, 10% of the global population suffers from chronic kidney disease , with diabetes and hypertension as significant risk factors. Disparities in care are also concerning, with diagnosed cardiometabolic diseases varying up to twofold among different racial and ethnic groups. In the U.S.,
DAIC
JANUARY 19, 2024
AVIM therapy is an investigational patented bioelectronic therapy, administered using a standard dual-chamber pacemaker, designed to immediately, substantially and persistently reduce blood pressure. This leaves a gap in the care of these patients and increases their risk for heart attack, stroke and heart failure progression.
Expert insights. Personalized for you.
40 
Let's personalize your content